CH512500A - Verfahren zur Herstellung von Phenazin-Derivaten - Google Patents
Verfahren zur Herstellung von Phenazin-DerivatenInfo
- Publication number
- CH512500A CH512500A CH1560067A CH1560067A CH512500A CH 512500 A CH512500 A CH 512500A CH 1560067 A CH1560067 A CH 1560067A CH 1560067 A CH1560067 A CH 1560067A CH 512500 A CH512500 A CH 512500A
- Authority
- CH
- Switzerland
- Prior art keywords
- phenazine
- formula
- oxide
- chloroform
- benzene
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 title abstract 2
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 title description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 13
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- FFISWZPYNKWIRR-UHFFFAOYSA-N 5-oxidophenazin-5-ium Chemical compound C1=CC=C2[N+]([O-])=C(C=CC=C3)C3=NC2=C1 FFISWZPYNKWIRR-UHFFFAOYSA-N 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 150000002988 phenazines Chemical class 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 230000000737 periodic effect Effects 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 48
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- 150000001875 compounds Chemical class 0.000 description 16
- 230000008018 melting Effects 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- -1 phenazine derivatives 1,6-phenazinediol-5, 10-dioxide Chemical class 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- SFNYAHCOEPIPGO-UHFFFAOYSA-N 1,6-dimethoxyphenazine Chemical compound C1=CC=C2N=C3C(OC)=CC=CC3=NC2=C1OC SFNYAHCOEPIPGO-UHFFFAOYSA-N 0.000 description 4
- NBMOVCYIGUDQJE-UHFFFAOYSA-N iodinin Chemical compound C1=CC=C2[N+]([O-])=C3C(O)=CC=CC3=[N+]([O-])C2=C1O NBMOVCYIGUDQJE-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- REXYCMKIWYTGET-UHFFFAOYSA-N 6-methoxy-10-oxidophenazin-10-ium-1-ol Chemical compound OC1=CC=CC2=NC3=C(C=CC=C3[N+](=C12)[O-])OC REXYCMKIWYTGET-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002026 chloroform extract Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- OGNXLFBCXQYFDB-UHFFFAOYSA-N 1,6-dimethoxyphenazine N(5),N(10)-dioxide Chemical compound [O-]N1C2=CC=CC(OC)=C2[N+](=O)C2=C1C(OC)=CC=C2 OGNXLFBCXQYFDB-UHFFFAOYSA-N 0.000 description 2
- YJPUKVVGBLRGID-UHFFFAOYSA-N 1,6-dimethoxyphenazine N(5)-oxide Chemical compound C1=CC=C2N=C3C(OC)=CC=CC3=[N+]([O-])C2=C1OC YJPUKVVGBLRGID-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- BMINBRPDZDJGSU-UHFFFAOYSA-N C(C)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC Chemical compound C(C)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC BMINBRPDZDJGSU-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 238000007361 Wohl-Aue reaction Methods 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- JIDVGUQUQSOHOL-UHFFFAOYSA-N myxin Chemical compound C1=CC=C2[N+]([O-])=C3C(OC)=CC=CC3=[N+]([O-])C2=C1O JIDVGUQUQSOHOL-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 2
- REUKXIFJVKFKDC-UHFFFAOYSA-N 1,2-dimethoxyphenazine Chemical compound C1=CC=CC2=NC3=C(OC)C(OC)=CC=C3N=C21 REUKXIFJVKFKDC-UHFFFAOYSA-N 0.000 description 1
- GWAAUIUHEAGBBM-UHFFFAOYSA-N 1,6-bis(phenylmethoxy)phenazine Chemical compound C(C1=CC=CC=C1)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC1=CC=CC=C1 GWAAUIUHEAGBBM-UHFFFAOYSA-N 0.000 description 1
- VBYCMICBXHTQHS-UHFFFAOYSA-N 1,6-dipropoxyphenazine Chemical compound C(CC)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCCC VBYCMICBXHTQHS-UHFFFAOYSA-N 0.000 description 1
- CYNFKYWHXHKBEN-UHFFFAOYSA-N 1-ethoxy-6-propoxyphenazine Chemical compound C(C)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCCC CYNFKYWHXHKBEN-UHFFFAOYSA-N 0.000 description 1
- FHYXQMGMICVTGE-UHFFFAOYSA-N 1-methoxy-6-phenylmethoxyphenazine Chemical compound C(C1=CC=CC=C1)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OC FHYXQMGMICVTGE-UHFFFAOYSA-N 0.000 description 1
- FJUMKIYHOCPWEZ-UHFFFAOYSA-N 1-methoxy-6-propoxyphenazine Chemical compound COC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCCC FJUMKIYHOCPWEZ-UHFFFAOYSA-N 0.000 description 1
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 1
- LBBOLLVFOUUAOU-UHFFFAOYSA-N 6-ethoxy-1-methoxy-5-oxidophenazin-5-ium Chemical compound COC1=CC=CC2=[N+](C3=C(C=CC=C3N=C12)OCC)[O-] LBBOLLVFOUUAOU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ROOKNWGFGPIAOV-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC Chemical compound C(C1=CC=CC=C1)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC ROOKNWGFGPIAOV-UHFFFAOYSA-N 0.000 description 1
- XSVZDOAQWCVXTR-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=CC=CC2=[N+](C3=C(C=CC=C3N=C12)OCC1=CC=CC=C1)[O-] Chemical compound C(C1=CC=CC=C1)OC1=CC=CC2=[N+](C3=C(C=CC=C3N=C12)OCC1=CC=CC=C1)[O-] XSVZDOAQWCVXTR-UHFFFAOYSA-N 0.000 description 1
- GPXMBAKKHRSRHU-UHFFFAOYSA-N COC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC Chemical compound COC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC GPXMBAKKHRSRHU-UHFFFAOYSA-N 0.000 description 1
- JUDKQQVKCWVNQZ-UHFFFAOYSA-N COC1=CC=CC2=NC3=C(C=CC=C3[N+](=C12)[O-])OCC Chemical compound COC1=CC=CC2=NC3=C(C=CC=C3[N+](=C12)[O-])OCC JUDKQQVKCWVNQZ-UHFFFAOYSA-N 0.000 description 1
- PZJDTLYEGJQMPR-UHFFFAOYSA-N COC1=CC=CC2=[N+](C3=C(C=CC=C3[N+](=C12)[O-])OCC)[O-] Chemical compound COC1=CC=CC2=[N+](C3=C(C=CC=C3[N+](=C12)[O-])OCC)[O-] PZJDTLYEGJQMPR-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000588881 Chromobacterium Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000187481 Mycobacterium phlei Species 0.000 description 1
- 125000000815 N-oxide group Chemical group 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005661 deetherification reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical class OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- CZPZWMPYEINMCF-UHFFFAOYSA-N propaneperoxoic acid Chemical compound CCC(=O)OO CZPZWMPYEINMCF-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Vehicle Body Suspensions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1048171A CH520694A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazin-Derivaten |
| CH503670A CH521358A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazinderivaten |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59679466A | 1966-11-25 | 1966-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH512500A true CH512500A (de) | 1971-09-15 |
Family
ID=24388733
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1560067A CH512500A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazin-Derivaten |
| CH503670A CH521358A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazinderivaten |
| CH1048171A CH520694A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazin-Derivaten |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH503670A CH521358A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazinderivaten |
| CH1048171A CH520694A (de) | 1966-11-25 | 1967-11-08 | Verfahren zur Herstellung von Phenazin-Derivaten |
Country Status (14)
| Country | Link |
|---|---|
| AT (2) | AT281851B (en]) |
| BE (1) | BE706861A (en]) |
| CA (1) | CA946397A (en]) |
| CH (3) | CH512500A (en]) |
| DE (2) | DE1795724C3 (en]) |
| ES (1) | ES347576A1 (en]) |
| FR (1) | FR1545331A (en]) |
| GB (1) | GB1142448A (en]) |
| GR (1) | GR38359B (en]) |
| IL (1) | IL28972A (en]) |
| NL (2) | NL6715787A (en]) |
| NO (1) | NO123528B (en]) |
| PH (2) | PH11778A (en]) |
| SE (3) | SE366988B (en]) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH532589A (de) * | 1969-05-14 | 1973-01-15 | Hoffmann La Roche | Verfahren zur Herstellung von Phenazin-Derivaten |
| US3681331A (en) * | 1970-04-02 | 1972-08-01 | Hoffmann La Roche | 1-hydroxy-6-amino alkoxy-phenazine 5,10-dioxides |
| CH575213A5 (en]) * | 1972-09-05 | 1976-05-14 | Ciba Geigy Ag | |
| CN104974100A (zh) * | 2015-07-07 | 2015-10-14 | 江苏省农业科学院 | 来源于抗生素溶杆菌oh13的吩嗪类化合物及其制备方法与应用 |
-
1967
- 1967-11-08 CH CH1560067A patent/CH512500A/de not_active IP Right Cessation
- 1967-11-08 CH CH503670A patent/CH521358A/de not_active IP Right Cessation
- 1967-11-08 CH CH1048171A patent/CH520694A/de not_active IP Right Cessation
- 1967-11-10 DE DE19671795724 patent/DE1795724C3/de not_active Expired
- 1967-11-10 DE DE19671695212 patent/DE1695212B2/de active Granted
- 1967-11-20 CA CA005,531A patent/CA946397A/en not_active Expired
- 1967-11-20 GR GR670138359A patent/GR38359B/el unknown
- 1967-11-20 IL IL2897267A patent/IL28972A/xx unknown
- 1967-11-21 NL NL6715787A patent/NL6715787A/xx unknown
- 1967-11-22 SE SE43872A patent/SE366988B/xx unknown
- 1967-11-22 AT AT1053467A patent/AT281851B/de not_active IP Right Cessation
- 1967-11-22 BE BE706861A patent/BE706861A/fr unknown
- 1967-11-22 SE SE1781070A patent/SE366985B/xx unknown
- 1967-11-22 AT AT01136/69A patent/AT281852B/de not_active IP Right Cessation
- 1967-11-22 SE SE1607067A patent/SE349036B/xx unknown
- 1967-11-22 GB GB5320167A patent/GB1142448A/en not_active Expired
- 1967-11-24 NO NO17069767A patent/NO123528B/no unknown
- 1967-11-24 ES ES347576A patent/ES347576A1/es not_active Expired
- 1967-11-24 FR FR129677A patent/FR1545331A/fr not_active Expired
-
1972
- 1972-01-03 PH PH13146A patent/PH11778A/en unknown
-
1974
- 1974-07-15 NL NL7409550A patent/NL7409550A/xx unknown
-
1976
- 1976-01-19 PH PH17992A patent/PH12441A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO123528B (en]) | 1971-12-06 |
| PH11778A (en) | 1978-07-05 |
| ES347576A1 (es) | 1969-02-01 |
| SE366988B (en]) | 1974-05-13 |
| CH520694A (de) | 1972-03-31 |
| SE366985B (en]) | 1974-05-13 |
| DE1795724B2 (de) | 1978-09-28 |
| DE1795724A1 (de) | 1974-02-28 |
| DE1695212B2 (de) | 1974-02-14 |
| NL7409550A (en]) | 1974-09-25 |
| GR38359B (el) | 1969-10-30 |
| IL28972A (en) | 1973-03-30 |
| CH521358A (de) | 1972-04-15 |
| FR1545331A (fr) | 1968-11-08 |
| DE1695212C3 (en]) | 1974-09-19 |
| SE349036B (en]) | 1972-09-18 |
| DE1795724C3 (de) | 1979-05-23 |
| DE1695212A1 (de) | 1971-03-18 |
| GB1142448A (en) | 1969-02-05 |
| AT281852B (en]) | 1970-06-10 |
| PH12441A (en) | 1979-03-01 |
| BE706861A (fr) | 1968-05-22 |
| AT281851B (de) | 1970-06-10 |
| CA946397A (en) | 1974-04-30 |
| NL6715787A (en]) | 1968-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2509260C3 (de) | a-(23,43,6-Penta-O-acetyl-D-gluconyl-thioureido)benzylpenicillin | |
| DE2745598A1 (de) | Arylschwefelverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
| DE2726820A1 (de) | Imidazothiazine | |
| CH512500A (de) | Verfahren zur Herstellung von Phenazin-Derivaten | |
| DE1793693C3 (en]) | ||
| DE1232577B (de) | Verfahren zur Herstellung von delta 4,9-3-Oxo-11beta-hydroperoxy-19-nor-steroiden | |
| DE1695375B2 (de) | 25-Desacetyl-rifamycin-SV-derivate u. Verfahren zu ihrer Herstellung | |
| AT349481B (de) | Verfahren zur herstellung von neuen morpholinderivaten, ihren n-oxiden und salzen | |
| DE2825445A1 (de) | Rifamycin-verbindungen | |
| DE2210121C3 (de) | Pyrido eckige Klammer auf 2,3-b eckige Klammer zu indole, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2101813C3 (de) | Neue 17alpha-(2',3'-difluormethylenprop-1 '-en-1 '-yl)-östra-4-en-3-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
| DE1695080A1 (de) | Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen | |
| DE1518654A1 (de) | Neue Cycloheptadiene | |
| DE3913310A1 (de) | Spirocyclopropane in der vitamin d-reihe | |
| DE1207381B (de) | Verfahren zur Herstellung von 2-Hydroxy-2-methylmercapto-indandion-(1, 3) | |
| DE2139016A1 (de) | Neue organische Verbindungen und Verfahren zu deren Herstellung | |
| DE1094258B (de) | Verfahren zur Herstellung von fluorierten 16-Methylsteroiden | |
| DE2023400A1 (en]) | ||
| DE1097985B (de) | Verfahren zur Herstellung von 4, 17ª‡-Dimethyl-9ª‡-fluor-11ª‰-oxytestosteron bzw. von 4, 17ª‡-Dimethyl-9ª‡-fluor-11-ketotestosteron | |
| DE1445875A1 (de) | Verfahren zur Herstellung enantiomerer Verbindungen aus der Dehydroemetin-Reihe | |
| DE1228609B (de) | Verfahren zur Herstellung von neuen 4-Halogen-3-keto-1, 4-androstadienen | |
| DE3129341A1 (de) | Bis-pyrimidin-nucleoside mit antiviraler aktivitaet, verfahren zu ihrer herstellung und daraus bereitete arzneiformen | |
| DE2130280A1 (de) | Verfahren zur Herstellung von in der 2- oder 3-Stellung ein Stickstoffatom aufweisenden Cholestanderivaten | |
| DE1117114B (de) | Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen | |
| DE2754718A1 (de) | Oleandomycin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |